Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. (ELVN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ELVN · as of Jun 8, 2026
Key Statistics
Explore Enliven Therapeutics, Inc. Data
elvn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The ELVN analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $67.00, representing +93.03% upside from the current price of $34.71.
Competitors & Peers
elvn competitorsELVN
ATAI
DNTH
IMTX
INBX
NKTRStock Performance
Full HistoryAbout Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecu…
what is enliven therapeutics, inc. · elvn stock overview · enliven therapeutics, inc. company profile · who is enliven therapeutics, inc. ceo · elvn NASDAQ · enliven therapeutics, inc. headquarters · enliven therapeutics, inc. business segments
About Stock Overview & Key Data
Enliven Therapeutics, Inc. (ELVN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 12, 2020. As of the latest trading session, ELVN stock price is $34.71, with a market capitalization of $2.1B. The stock has returned +70.65% over the past 12 months and +125.39% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Enliven Therapeutics, Inc. stock is Buy, with an average 12-month price target of $67.00. In fiscal year 2025, Enliven Therapeutics, Inc. reported revenue of — and net income of -$103.7M. For detailed data — including Enliven Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enliven Therapeutics, Inc. (ELVN) stock price is $34.71. The stock is traded on NASDAQ under the ticker symbol ELVN. The 52-week range is $14.79 – $48.53.